![James L. Knighton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James L. Knighton
Gründer bei
Pylum Biosciences, Inc.
Profil
James L.
Knighton is the founder of Xyphos Biosciences, Inc. (founded in 2017) and AvidBiotics Corp.
(founded in 2005), where he held the titles of Chief Executive Officer & Director and President & Director respectively.
Mr. Knighton is also the founder of Pylum Biosciences, Inc...
Mr. Knighton's former job positions include Director at Pharmacyclics LLC (2006-2009), VP-Investor Relations & Corporate Communications at Chiron Corp.
(1997-1998), Chief Financial Officer & Senior Vice President at Sugen, Inc. (1998-1999), President at Caliper Life Sciences, Inc. (1999-2004), and Vice President-Strategic Planning & Finance at DuPont Merck Pharmaceutical Co. (1985-1994).
Mr. Knighton's education includes a graduate degree from the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von James L. Knighton
| Unternehmen | Position | Beginn |
|---|---|---|
Pylum Biosciences, Inc.
 Pylum Biosciences, Inc. BiotechnologyHealth Technology Develops avidocin platform technology capable of generating bactericidal protein complexes | Gründer | - |
Ehemalige bekannte Positionen von James L. Knighton
| Unternehmen | Position | Ende |
|---|---|---|
Xyphos Biosciences, Inc.
 Xyphos Biosciences, Inc. BiotechnologyHealth Technology Engages in biotechnology business | Gründer | 01.01.2019 |
AvidBiotics Corp.
 AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology Develops non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancer | Gründer | 01.11.2017 |
| PHARMACYCLICS, INC. | Direktor/Vorstandsmitglied | 15.01.2009 |
Caliper Life Sciences, Inc.
 Caliper Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells lab chip systems | Präsident | 01.01.2004 |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Finanzdirektor/CFO | 01.09.1999 |
Ausbildung von James L. Knighton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells lab chip systems | Health Technology |
AvidBiotics Corp.
AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology Develops non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancer | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Develops avidocin platform technology capable of generating bactericidal protein complexes | Health Technology |
Xyphos Biosciences, Inc.
Xyphos Biosciences, Inc. BiotechnologyHealth Technology Engages in biotechnology business | Health Technology |
